Stay updated on Tagraxofusp in CD123+ AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.

Latest updates to the Tagraxofusp in CD123+ AML Clinical Trial page
- Check6 days agoChange DetectedThe study record versions now include a new revision entry v3.3.4 and remove v3.3.3 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page history now shows a new revision label 'Revision: v3.3.3', and the entries for 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' appear to be removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedRecord History now lists an added Revision: v3.3.2 and a removed Revision: v3.2.0. These are maintenance entries to the history log rather than changes to study records.SummaryDifference0.1%

- Check63 days agoChange DetectedThe notice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check78 days agoChange DetectedRecord history shows updates to Study Status and Recruitment Status across versions. Version 2 (2020-09-16) changed Study Status; Version 3 (2021-12-17) changed Recruitment Status; Version 4 (2025-01-28) updated Recruitment Status, Study Status, Study Design, and Contacts/Locations.SummaryDifference0.1%

- Check106 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference13%

Stay in the know with updates to Tagraxofusp in CD123+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in CD123+ AML Clinical Trial page.